| 6730- | Dipy, | ASA, | Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner |
| - | vitro+vivo, | CRC, | NA |
| 6731- | Dipy, | Dipyridamole, an underestimated vascular protective drug |
| - | Review, | Nor, | NA |
| 6733- | Dipy, | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress |
| - | in-vivo, | Diabetic, | NA |
| 6734- | Dipy, | Cisplatin, | Adenosine enhances cisplatin sensitivity in human ovarian cancer cells |
| - | in-vitro, | Ovarian, | NA |
| 6735- | Dipy, | Dipyridamole Reverses Peripheral Ischemia and Induces Angiogenesis in the Db/Db Diabetic Mouse Hind Limb Model by Decreasing Oxidative Stress |
| - | in-vivo, | Nor, | NA |
| 6736- | Dipy, | Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine |
| 6737- | Dipy, | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD) |
| - | Trial, | Nor, | NA |
| 6278- | DL, | Safety evaluation and risk assessment of d-Limonene |
| - | Review, | Nor, | NA |
| 6289- | DL, | D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis |
| - | in-vivo, | Var, | NA |
| 6290- | DL, | Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells |
| - | in-vitro, | AML, | K562 | - | in-vitro, | AML, | HL-60 |
| 6265- | DL, | Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee |
| - | Trial, | Var, | NA |
| 6266- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer |
| - | Trial, | BC, | NA |
| 6267- | DL, | Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis |
| - | Review, | BC, | NA |
| 6268- | DL, | Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2) |
| - | in-vitro, | Liver, | HepG2 |
| 6269- | DL, | Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells |
| - | in-vitro, | CRC, | LS174T |
| 6270- | DL, | d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | H1299 |
| 6271- | DL, | D-limonene rich volatile oil from blood oranges inhibits angiogenesis, metastasis and cell death in human colon cancer cells |
| - | in-vitro, | Colon, | SW480 | - | in-vitro, | Colon, | HT-29 |
| 6272- | DL, | Anti‐leukemic and anti‐angiogenic effects of d‐Limonene on K562‐implanted C57BL/6 mice and the chick chorioallantoic membrane model |
| - | vitro+vivo, | CLL, | NA |
| 6273- | DL, | D-Limonene Exhibits Antiproliferative Activity Against Human Colorectal Adenocarcinoma (Caco-2) Cells via Regulation of Inflammatory and Apoptotic Pathways |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | Colon, | HCT116 |
| 6274- | DL, | Protective Effect of D-Limonene against Oxidative Stress-Induced Cell Damage in Human Lens Epithelial Cells via the p38 Pathway |
| - | in-vitro, | Nor, | NA |
| 6275- | DL, | Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans |
| - | in-vivo, | Col, | NA |
| 6277- | DL, | docx, | d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Nor, | PZ-HPV-7 |
| 6288- | DL, | From Citrus to Clinic: Limonene’s Journey Through Preclinical Research, Clinical Trials, and Formulation Innovations |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6287- | DL, | D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis |
| - | in-vivo, | Covid, | NA |
| 6286- | DL, | d-Limonene inhibits cytokines and chemokines expression by regulating NF-kappaB and STAT in HaCat cells and DNCB-induced atopic dermatitis in BALB/c mice |
| - | in-vitro, | Nor, | NA |
| 6285- | DL, | Limonin inhibits angiogenesis and metastasis of human breast cancer cells by suppressing the VEGFR2/IGFR1-mediated STAT3 signaling pathway |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 6284- | DL, | Chemoprevention and therapy of cancer by d-limonene |
| - | in-vivo, | Var, | NA |
| 6282- | DL, | Limonene Exerts Anti-Inflammatory Effect on LPS-Induced Jejunal Injury in Mice by Inhibiting NF-κB/AP-1 Pathway |
| - | in-vivo, | IBD, | NA |
| 6281- | DL, | Applications of Limonene in Neoplasms and Non-Neoplastic Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Diabetic, | NA |
| 6280- | DL, | Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs |
| - | Review, | Var, | NA |
| 6279- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer |
| - | Trial, | BC, | NA |
| 6276- | DL, | Tam, | Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 6283- | DL, | D-limonene inhibits peritoneal adhesion formation in rats via anti-inflammatory, anti-angiogenic, and antioxidative effects |
| - | in-vivo, | Nor, | NA |
| 6728- | DMSO, | Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes |
| - | in-vitro, | Nor, | NA |
| 6727- | DMSO, | The permeability enhancing mechanism of DMSO in ceramide bilayers simulated by molecular dynamics |
| 6726- | DMSO, | DMSO induces apoptosis in SV40-transformed human keratinocytes, but not in normal keratinocytes |
| - | in-vitro, | NA, | NA |
| 6725- | DMSO, | DMSO induces dehydration near lipid membrane surfaces |
| - | Study, | Nor, | NA |
| 6724- | DMSO, | Ion transport through dimethyl sulfoxide (DMSO) induced transient water pores in cell membranes |
| - | in-vitro, | Nor, | NA |
| 6723- | DMSO, | Modulating the structure and properties of cell membranes: the molecular mechanism of action of dimethyl sulfoxide |
| - | Review, | Nor, | NA |
| 5386- | docx, | AsP, | Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy |
| - | vitro+vivo, | Liver, | HepG2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 |
| 6328- | DRE, | Hydroalcoholic extract of Taraxacum officinale induces apoptosis and autophagy in 4T1 breast cancer cells |
| - | in-vitro, | BC, | 4T1 |
| 6329- | DRE, | VitA,RetA, | Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 6342- | DRE, | Mechanistic Study on the Inhibitory Effect of Dandelion Extract on Breast Cancer Cell Proliferation and Its Induction of Apoptosis |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 6343- | DRE, | Dandelion root extract affects ESCC progression via regulating multiple signal pathways |
| - | vitro+vivo, | ESCC, | NA |
| 6344- | DRE, | Dandelion: Purported Benefits, Side Effects & More |
| - | Review, | Var, | NA |
| 6345- | DRE, | Human clinical trials on for cancer killing dandelion extract |
| - | Review, | AML, | NA |
| 6346- | DRE, | Unusual Response of Acute Monocytic Leukemia to Dandelion Root Extract |
| - | Case Report, | AML, | NA |
| 6347- | DRE, | Protective Effects of Taraxacum officinale L. (Dandelion) Root Extract in Experimental Acute on Chronic Liver Failure |
| 6348- | DRE, | New prospects in oncotherapy: bioactive compounds from Taraxacum officinale |
| - | Review, | Var, | NA |
| 6349- | DRE, | Dandelion root extract protects NCM460 colonic cells and relieves experimental mouse colitis |
| - | vitro+vivo, | Nor, | NCM460 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid